Type 2 Diabetes Trial, Recruiting NCT06323538 Sponsor: German Federal Institute for Risk Assessment Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06323538
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 69 years old at the time of joining (the trial aims to include equal numbers of people across four age groups: 18–29, 30–39, 40–49, and 50–69)
  • People who have been following their current diet for at least one year
  • People who have health insurance
  • People who are willing to have blood samples taken
  • People who are willing and able to fill out questionnaires
  • At the Berlin, Jena, Giessen, and Karlsruhe locations only: pregnant and breastfeeding women may be included, with a shorter set of tests
  • At the Regensburg, Heidelberg, Bonn, and Vienna locations only: people who are not pregnant and not breastfeeding at the time of joining
  • At the Berlin and Karlsruhe locations only: children of adult participants may be included, with a shorter set of tests that does not involve blood, urine, or stool collection
  • People who are able to give informed consent to take part in the study
  • People who have already agreed to take part in the broader COPLANT study

Who may not be able to join:

  • People who can no longer be contacted by the research team
  • People who have withdrawn their consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ute Nöthlings, Prof, University of Bonn

Phone: +49 30 184155000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
German Federal Institute for Risk Assessment
Registry
ClinicalTrials.gov
Start date
9 April 2024
Est. completion
31 March 2027

Where this trial is recruiting

🇦🇹 Austria 🇩🇪 Germany

Primary endpoints

Incidence of diabetes type 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov